HomeTrialNCT07215585
🔬NCT07215585Phase 3RECRUITING

AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL

Study Summary

The purpose of this study is to measure the efficacy and safety of R-mini-CHOP × 2 followed by AZD0486 compared with R-mini-CHOP × 6 in elderly or unfit participants newly diagnosed with LBCL.

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment420 participants
Primary Completion
Lead SponsorAstraZeneca
Data Retrieved2026-04-11 02:55:19.911269+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.